Luye Pharma Group Ltd. is an investment holding company, which engages in the developing, producing, marketing, and selling of pharmaceutical products. The company is headquartered in Yantai, Shandong and currently employs 5,150 full-time employees. The company went IPO on 2014-07-09. The firm operates four segments, including Oncology Drugs segment, Cardiovascular System Drugs segment, Alimentary Tract and Metabolism Drugs segment, and Central Nervous System Drugs segment. The Oncology Drugs segment provides Lipusu, Boyounuo, Baituowei, CMNa and Mimeixin and other drugs. The Cardiovascular System Drugs segment provides Xuezhikang, Oukai and Maitongna and other drugs. The Alimentary Tract and Metabolism Drugs segment provides Bei Xi and other drugs. The Central Nervous System Drugs segment provides Seroquel, Ruoxinlin, Rykindo, Meibirui and Jinyouping and other drugs.
Follow-Up Questions
LYPHF の株価パフォーマンスは？
LYPHF の現在の価格は $0 で、最終取引日から 0% decreased 変動しました。
Luye Pharma Group Ltd の主な事業テーマや業界は？
Luye Pharma Group Ltd は Pharmaceuticals 業界、セクターは Health Care に属しています。
